Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Ebglyss“
Suchtreffer
Begriffe & Kennungen
Ebglyss · 4.8 · Description of selected adverse reactions
Eintrag öffnenEbglyss · 4.8 · During the first 16 weeks of treatment conjunctivitis, conjunctivitis allergic, blepharitis and keratitis were
Eintrag öffnenEbglyss · 4.8 · Eosinophilia
Eintrag öffnenEbglyss · 4.8 · Herpes zoster was reported in 0.6% of the patients treated with lebrikizumab and none of the patients in the p
Eintrag öffnenEbglyss · 4.8 · Injection site reactions
Eintrag öffnenEbglyss · 4.8 · Injection site reactions (including pain and erythema) were reported more frequently in patients who received
Eintrag öffnenEbglyss · 4.8 · Lebrikizumab-treated patients had a greater mean increase from baseline in eosinophil count compared to patien
Eintrag öffnenEbglyss · 4.8 · Long term safety
Eintrag öffnenEbglyss · 4.8 · Paediatric population
Eintrag öffnenEbglyss · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenEbglyss · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEbglyss · 4.8 · Summary of the safety profile
Eintrag öffnenEbglyss · 4.8 · Table 1. List of adverse reactions MedDRA System Frequency Adverse reaction Organ Class Infections and Common
Eintrag öffnenEbglyss · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenEbglyss · 4.8 · The most common adverse reactions are conjunctivitis (6.9%), injection site reactions (2.6%), conjunctivitis a
Eintrag öffnenEbglyss · 4.8 · The safety of lebrikizumab was assessed in 372 patients 12 to 17 years of age with moderate-to-severe atopic d
Eintrag öffnenEbglyss · 4.8 · The safety of lebrikizumab was assessed in adults and adolescents with up to 3 years of continuous treatment.
Eintrag öffnen